A detailed history of Cedar Mountain Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 52 shares of AMGN stock, worth $16,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$16,408
Previous $16,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 14, 2022

SELL
$230.71 - $256.74 $6,229 - $6,931
-27 Reduced 34.18%
52 $13,000
Q3 2021

Oct 15, 2021

BUY
$212.27 - $248.7 $5,731 - $6,714
27 Added 51.92%
79 $16,000
Q2 2020

Jul 20, 2020

BUY
$197.81 - $242.74 $5,143 - $6,311
26 Added 100.0%
52 $12,000
Q4 2019

Jan 30, 2020

BUY
$189.21 - $243.2 $4,919 - $6,323
26 New
26 $6,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.